Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RTFDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GCNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CIAPIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEX261 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ROCK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGRMC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAP130 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAPBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CARMIL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on